Mark J Gergen - Net Worth and Insider Trading
Mark J Gergen Net Worth
The estimated net worth of Mark J Gergen is at least $7 Million dollars as of 2024-12-27. Mark J Gergen is the Executive Chairman of Poseida Therapeutics Inc and owns about 651,291 shares of Poseida Therapeutics Inc (PSTX) stock worth over $6 Million. Mark J Gergen is also the Executive VP, COO of Mirati Therapeutics Inc and owns about 5,748 shares of Mirati Therapeutics Inc (MRTX) stock worth over $337,408. Details can be seen in Mark J Gergen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark J Gergen has not made any transactions after 2024-12-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark J Gergen
Mark J Gergen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark J Gergen owns 3 companies in total, including Poseida Therapeutics Inc (PSTX) , Halozyme Therapeutics Inc (HALO) , and Mirati Therapeutics Inc (MRTX) .
Click here to see the complete history of Mark J Gergen’s form 4 insider trades.
Insider Ownership Summary of Mark J Gergen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PSTX | Poseida Therapeutics Inc | 2024-12-10 | director & President and CBO |
| HALO | Halozyme Therapeutics Inc | 2016-09-01 | SVP & Chief Operating Officer |
| MRTX | Mirati Therapeutics Inc | 2016-01-15 | Executive VP & COO |
Mark J Gergen Latest Holdings Summary
Mark J Gergen currently owns a total of 2 stocks. Among these stocks, Mark J Gergen owns 651,291 shares of Poseida Therapeutics Inc (PSTX) as of December 10, 2024, with a value of $6 Million and a weighting of 94.83%. Mark J Gergen also owns 5,748 shares of Mirati Therapeutics Inc (MRTX) as of January 15, 2016, with a value of $337,408 and a weighting of 5.17%.
Latest Holdings of Mark J Gergen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PSTX | Poseida Therapeutics Inc | 2024-12-10 | 651,291 | 9.51 | 6,193,777 |
| MRTX | Mirati Therapeutics Inc | 2016-01-15 | 5,748 | 58.70 | 337,408 |
Holding Weightings of Mark J Gergen
Mark J Gergen Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark J Gergen has made a total of 2 transactions in Poseida Therapeutics Inc (PSTX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Poseida Therapeutics Inc is the sale of 30,000 shares on December 10, 2024, which brought Mark J Gergen around $283,800.
According to the SEC Form 4 filings, Mark J Gergen has made a total of 0 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years. The most-recent trade in Mirati Therapeutics Inc is the sale of 10,000 shares on January 15, 2016, which brought Mark J Gergen around $259,200.
Insider Trading History of Mark J Gergen
- 1
Mark J Gergen Trading Performance
Mark J Gergen Ownership Network
Mark J Gergen Owned Company Details
What does Poseida Therapeutics Inc do?
Who are the key executives at Poseida Therapeutics Inc?
Mark J Gergen is the director & President and CBO of Poseida Therapeutics Inc. Other key executives at Poseida Therapeutics Inc include President & Cell Therapy Kristin Yarema , 10 percent owner Malin Life Sciences Holdings Ltd , and director & 10 percent owner & Chief Executive Officer Eric Ostertag .
Poseida Therapeutics Inc (PSTX) Insider Trades Summary
Over the past 18 months, Mark J Gergen made 2 insider transaction in Poseida Therapeutics Inc (PSTX) with a net sale of 60,000.
In summary, during the past 3 months, insiders sold 60,000 shares of Poseida Therapeutics Inc (PSTX) in total and bought 0 shares, with a net sale of 60,000 shares. During the past 18 months, 60,000 shares of Poseida Therapeutics Inc (PSTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 60,000 shares.
Poseida Therapeutics Inc (PSTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Poseida Therapeutics Inc Insider Transactions
Mark J Gergen Mailing Address
Above is the net worth, insider trading, and ownership report for Mark J Gergen. You might contact Mark J Gergen via mailing address: C/o Mirati Therapeutics Inc., 9393 Town Centre Drive, Ste 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
